A program added to usual care
The researchers randomly assigned 46 people with systemic sclerosis to two groups of 23. The intervention group received an exercise program in addition to the standard protocol, while the control group followed the standard protocol.
After an initial interview, the program's video materials were transferred to the phones of participants in the intervention group. However, the abstract does not detail the exercises, their frequency or the length of the sessions. It therefore does not allow the program to be replicated.
Assessments took place at baseline, then at 4, 8 and 12 weeks. They covered hand function, measured using the Duruöz Hand Index, mouth opening and quality of life, assessed using the WHOQOL-BREF questionnaire.
A favorable signal, without a quantified magnitude
At the final follow-up, the authors report statistically significant differences between the groups in hand function, oral function and quality of life, favoring the exercise program.
But the abstract provides neither the scores obtained in each group, nor the magnitude of the differences, nor their confidence intervals. A statistically significant difference is not enough to establish that the change is large enough to be noticeable or useful in everyday life.
The finding concerns a program added to usual care. It does not show that exercises can replace disease management or that they affect the course of the disease.
A conclusion limited to the population studied
Participants had a mean age of 51.7 years and were overwhelmingly women. With this small sample, the findings still need confirmation and cannot automatically be generalized to everyone with systemic sclerosis.
Follow-up ends at 12 weeks in the abstract. Whether the benefits persist beyond that point is therefore not established. Adherence to the program, any adverse effects and the procedures for blinding assessors are not specified in the excerpt reviewed.
Limitations to keep in mind
Only the PubMed abstract was reviewed, not the full text. The sample is small, the population overwhelmingly female and follow-up limited to 12 weeks. The magnitude of the effects, their clinical relevance, tolerability, funding and conflicts of interest cannot be verified from the material provided.
What we can take away
This trial supports the potential value of supplementary exercises for certain everyday functions in systemic sclerosis. It does not yet allow the expected benefit to be quantified or a reproducible program to be proposed.
Sources and provenance
- The effect of exercise program applied to patients with scleroderma on functional outcomes: A randomized controlled trial.
Source date: 2026-11-04.
Journal Article, Randomized Controlled Trial · Résumé PubMed uniquement, texte intégral non consulté


